Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IBM Research is the research and development division of IBM and operates as a global industrial research organization spanning artificial intelligence, quantum computing, semiconductors, and hybrid cloud. Within healthcare and life sciences, it develops computational platforms, biomedical foundation models, multimodal AI systems, and discovery tools aimed at biomarker discovery, drug discovery, protein design, clinical decision support, and multi-omics analysis. The group collaborates with healthcare systems, nonprofits, and academic institutions rather than advancing a traditional proprietary therapeutic pipeline. Its health-related work is centered on enabling research and translational discovery through software, data, and computing infrastructure, including projects in antibody-antigen modeling, patient data analysis, and quantum-enabled biomedical research. For a biotech analyst, IBM Research is best understood as a technology and platform organization with meaningful exposure to healthcare R&D, not as a conventional biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IBM Research.